DICE Therapeutics (NASDAQ:DICE) reported quarterly losses of $(0.55) per share. This is a 74.42 percent increase over losses of $(2.15) per share from the same period last year.
Baker Hughes And Snam Collaborate On Hydrogen-Ready Pipeline
Baker Hughes chosen to supply three state-of-the-art turbocompressors with hydrogen-ready technology to Snam SPA, reducing carbon emissions in Italian gas infrastructure.
